Red Light Therapy vs Shockwave for Horses: One Breaks to Build — the Other Builds Without Breaking
Share
These two therapies sit at opposite ends of the tissue-stimulation spectrum, and understanding the difference before your vet recommends one is worth the five minutes this guide takes to read. Shockwave therapy (ESWT) creates controlled microtrauma — it deliberately damages tissue to trigger a repair cascade. High-pressure acoustic waves disrupt cells, fracture calcifications, and stimulate the body's mechanotransduction pathways to rebuild. Red light therapy (PBM) does the opposite: it stimulates cellular repair without causing any tissue damage — photons absorbed by cytochrome c oxidase increase ATP production, release nitric oxide, and modulate inflammation through a photochemical pathway that disrupts nothing. ESWT breaks to build. PBM builds without breaking. These are not two versions of the same therapy. They are different healing philosophies. Our guide to how PBM works covers the cellular mechanism in detail.
The second point is one that matters for competition horse owners and anyone managing an injury: ESWT masks pain. The analgesic effect is so significant that the standard protocol requires 72 hours of rest after each session — because the horse may not feel pain that should be telling it to stop loading the injured structure. The FEI and most competition bodies prohibit ESWT within five days of competition specifically because of this pain-masking effect. PBM does not produce this level of analgesia. It may support comfort through inflammatory modulation, but it does not create the substantial numbing that ESWT does. This means PBM carries no competition restriction and no risk of a horse performing on an injury it cannot feel. Our combination therapy guide covers how these modalities fit together in a broader protocol.
And the third point is the access model: ESWT is a vet-administered clinical procedure costing $200–500+ per session, repeated three to five times at two-to-four-week intervals. PBM is an owner-applied daily therapy with no per-session cost after the device purchase. This is not just a cost difference — it determines who controls the therapy, how often it happens, and what happens between treatments. ESWT gives you three to five high-intensity interventions over two to three months. PBM gives you 60+ daily support sessions in the same period. They serve different roles: ESWT is the periodic heavy stimulus. PBM is the daily cellular maintenance. And when used together — PBM routine between ESWT sessions — they cover more therapeutic ground than either alone.
The Short Answer
ESWT breaks tissue to trigger repair. PBM stimulates repair without breaking anything. Different philosophies, different risk profiles, different access models.
ESWT: vet-administered, requires sedation, $200–500+/session, 3–5 sessions over 2–3 months. Strong equine evidence for suspensory desmitis, navicular syndrome, OA. Significant pain masking (72 hr rest post-treatment, competition restrictions).
PBM: owner-applied daily, no sedation, no per-session cost. Well-characterised cellular mechanism. Broader evidence base overall. No pain masking, no competition restriction.
Together: ESWT provides periodic high-intensity stimulus. PBM provides daily cellular support between sessions. Complementary, not competing.
The Mechanism Comparison: Destruction vs Construction
| Shockwave (ESWT) | Red light therapy (PBM) | |
|---|---|---|
| Physics | Acoustic — high-pressure sound waves delivered through a probe | Photonic — photons at 660 nm and 810–850 nm from LED arrays |
| Mechanism | Mechanotransduction. Controlled microtrauma disrupts tissue → triggers repair cascade: neovascularisation, growth factor release, collagen remodelling, bone formation | Photochemistry. Photons absorbed by CCO → ATP production increase, NO release (vasodilation), inflammatory mediator modulation. No tissue disruption |
| Healing philosophy | Break to build. Deliberately create damage that forces the body to rebuild — similar to exercise-induced adaptation but at higher intensity | Build without breaking. Provide cellular fuel and optimise the repair environment without causing any damage to trigger it |
| Tissue impact | Creates microtrauma, potential microfractures, local tissue disruption. Controlled, but real. Can cause white hair growth at treatment site | No tissue damage at consumer LED power densities. Non-thermal, non-disruptive. No structural risk |
| Pain effect | Significant analgesia. Numbs the treated area for days. 72-hour rest mandated. FEI restricts use within 5 days of competition | Modest comfort support. May modulate pain mediators. No significant analgesic masking. No competition restriction |
| Administered by | Veterinarian only. Requires sedation, anatomical precision, clinical judgment about dose and energy | Owner. No sedation, no special training. Device placed on the area, timer started |
| Frequency | 3–5 sessions, 2–4 weeks apart | Daily or near-daily, indefinitely if needed |
| Cost per treatment cycle | $600–2,500+ (3–5 vet visits × $200–500 each) | $0 per session after device purchase (device: $150–600 depending on type) |
The philosophical difference matters
These are not just different devices — they represent genuinely different approaches to healing. ESWT says: "the tissue is stuck in a non-healing state; we need to disrupt it to restart the repair process." PBM says: "the tissue is repairing, but slowly; we need to provide more cellular fuel and optimise the repair environment."
For chronic, non-healing conditions — a suspensory ligament that has not improved after months of rest, a navicular syndrome that has plateaued, an OA joint that is not responding to conservative management — ESWT's destructive-to-reconstruct approach may be exactly what the tissue needs. For tissue that is actively healing and needs support — a post-surgical site, a recovering tendon, a wound closing, a chronically stiff back — PBM's constructive-without-destroying approach fits better.
The question is not "which is better?" It is "what does the tissue need — a restart or support?"
The Pain Masking Problem: Why ESWT Has Competition Restrictions
This is the most important practical difference between the two modalities for competition horse owners — and one that matters for any horse manager, regardless of whether the horse competes.
ESWT produces a well-documented analgesic effect that extends well beyond the treatment session. The mechanism involves alteration of nerve signalling, reduction of substance P, and desensitisation of nociceptors (pain receptors) in the treated area. The effect can last for days.
Why this matters
- The horse cannot tell you it hurts. If the analgesic effect masks pain from an ongoing or worsening injury, the horse may load a structure it should be protecting. This is why 72 hours of rest after each ESWT session is the standard protocol — to prevent the horse from performing on an injury it cannot feel.
- Competition bodies restrict ESWT. The FEI prohibits ESWT within five days of competition. Many national federations have similar rules. The concern is straightforward: a horse that cannot feel a structural injury may compete, collapse, or catastrophically fail.
- Assessment becomes harder. As one equine vet candidly noted in the literature: "I personally find it hard to assess healing of an injury using this treatment because it is so hard to know how it would have healed without the treatment." The pain masking confounds both the horse's behaviour and the vet's clinical assessment.
How PBM differs on pain
PBM may modulate pain through reduction of inflammatory mediators (prostaglandins, bradykinin, substance P) and through improved local circulation clearing pain-causing metabolites. But this effect is modest compared to ESWT's analgesic effect — it supports comfort rather than masking pain. A horse on daily PBM that is still lame is telling you something meaningful. A horse 48 hours after ESWT that seems sound may or may not be healed — the pain masking prevents the horse's behaviour from being a reliable indicator. PBM carries no competition restriction from any governing body precisely because it does not produce significant analgesic masking.
Evidence Comparison: Where Each Has the Stronger Case
| Condition | ESWT equine evidence | PBM equine evidence | Which has the edge? |
|---|---|---|---|
| Proximal suspensory desmitis | Strong. AAEP position statement endorses. Multiple clinical studies showing reduced lameness and improved function | Limited direct evidence for this specific condition | ESWT |
| Navicular syndrome | Promising. Studies showing improved soundness in refractory cases. Deep tissue access via acoustic waves | Limited — photon penetration through the hoof wall is a barrier | ESWT |
| SDFT tendinitis | Evidence exists but variable. Some studies show improved healing; others show limited advantage over rest alone | Evidence exists — in vitro equine tenocyte studies positive; controlled in vivo studies promising for collagen organisation | Both have evidence — different mechanisms, potentially complementary |
| Osteoarthritis | Evidence exists. High-energy ESWT shown to reduce lameness scores in OA horses refractory to other treatments | Evidence exists — mechanism well-suited (inflammation modulation, circulation) but equine-specific OA studies still limited | Both have a case — ESWT for refractory OA, PBM for daily management |
| Kissing spines / back pain | Clinical use is growing. Evidence for pain reduction; remodelling of impinging dorsal spinous processes | Supportive — PBM for surrounding muscle comfort and recovery, but not for bony structural remodelling | ESWT for the bone pathology; PBM for soft tissue support around it |
| Wound healing | Some evidence for non-healing wounds | Strong mechanism fit. Fibroblast stimulation, collagen synthesis, epithelialisation. Broader evidence base across species | PBM |
| Post-exercise muscle recovery | Not a typical ESWT application | Strong. Extensive DOMS evidence. ATP stimulation, vasodilation, waste clearance all well-suited | PBM |
| General wellness / senior comfort | Not appropriate — ESWT is a treatment, not a maintenance tool | Well-suited — daily, low-risk, owner-applied, supports ongoing comfort | PBM |
The pattern that emerges
ESWT has the edge for specific, chronic, structural conditions that have not responded to conservative management — particularly in dense connective tissue (suspensory ligament) and bone (navicular, OA, kissing spines). These are conditions where the tissue may need the mechanotransduction "restart" that ESWT provides.
PBM has the edge for daily support, recovery, wound healing, and accessible soft tissue — conditions where the tissue is actively healing and needs cellular fuel, not disruption. It also has the edge for ongoing maintenance — the daily comfort support that ESWT is not designed to provide.
ESWT is a treatment. PBM is a practice. One is what the vet does three to five times. The other is what you do 300 times a year.
The Access Model: Why It Changes Everything
| ESWT | PBM | |
|---|---|---|
| Who administers | Veterinarian — requires clinical training, anatomical knowledge, dose judgment | Owner — device placed on the area, timer started |
| Sedation | Yes — light sedation typically required. The procedure produces acoustic noise and tissue discomfort | No — most horses stand calmly. No discomfort during application |
| Session frequency | Every 2–4 weeks, 3–5 sessions total | Daily or near-daily, ongoing as needed |
| Total sessions per treatment course | 3–5 | 60–90+ (daily for 2–3 months) |
| Cost per treatment course | $600–2,500+ (vet fees × sessions) | $150–600 one-time device purchase, then $0/session |
| Post-treatment restriction | 72 hours rest after each session (pain masking) | None — horse can resume normal activity immediately |
| Competition restriction | Yes — FEI prohibits within 5 days of competition | None |
| Risk profile | Potential microfractures, white hair growth, premature growth plate closure in young horses. Must be anatomically targeted | No tissue risk at consumer LED power densities. Non-thermal, non-disruptive |
What happens between ESWT sessions
ESWT is administered every two to four weeks. Between sessions, the tissue is responding to the mechanotransduction stimulus — remodelling, forming new blood vessels, synthesising growth factors. During those two to four weeks, what is supporting the cellular response? If the answer is "nothing beyond rest and time," the tissue is healing on its own biological clock. If the answer is "daily PBM," the tissue has additional ATP fuel, enhanced local circulation, and modulated inflammation supporting the repair response every day between the vet's visits. This is the combination argument: ESWT triggers the repair. PBM fuels it — every day, not just on treatment day.
When to Choose Each — or Both
| Situation | Recommendation | Why |
|---|---|---|
| Chronic suspensory desmitis not responding to rest | ESWT (vet-administered) + daily PBM between sessions | ESWT has the strongest equine evidence here. PBM fills the gaps between ESWT sessions with daily cellular support |
| Navicular syndrome (refractory) | ESWT — acoustic waves penetrate the hoof; photons largely do not | Depth access is ESWT's advantage. Photon attenuation through the hoof wall limits PBM's reach to navicular structures |
| Wound healing | PBM | Non-contact, non-disruptive, daily, owner-applied. ESWT is microtrauma — not appropriate for a healing wound in most cases |
| Post-exercise recovery | PBM | Daily, low-intensity, owner-applied. ESWT is not a recovery tool — it is a treatment for specific pathology |
| Kissing spines | ESWT for the bony pathology + PBM for surrounding muscle comfort | ESWT addresses the structural problem (impinging spinous processes). PBM supports the overlying muscle tissue's comfort and recovery |
| Osteoarthritis (active management) | PBM daily for ongoing comfort + ESWT if condition is refractory | PBM for daily management is practical and evidence-supported. ESWT reserved for cases that do not respond to conservative approaches |
| Senior horse wellness | PBM | ESWT is a treatment, not a maintenance tool. PBM's daily, gentle, owner-applied model fits long-term wellness support |
| Competition horse needing therapy close to an event | PBM | No competition restriction. ESWT prohibited within 5 days of competition (FEI). PBM can be used up to and on competition day |
The Complementary Protocol: How They Work Together
ESWT triggers. PBM fuels. The tissue gets both.
- ESWT session (vet, every 2–4 weeks): the vet administers shockwave to the targeted structure — suspensory ligament, joint surface, navicular region. The mechanotransduction stimulus triggers neovascularisation, growth factor release, and tissue remodelling.
- 24–48 hours post-ESWT: rest. The tissue is responding to the microtrauma. Pain masking is in effect. No PBM during this immediate window — let the tissue's initial response to the shockwave stimulus proceed without additional stimulation.
- 48+ hours post-ESWT through to next session: daily PBM on the treated area. Each session provides ATP for the cellular repair process the shockwave triggered, NO-mediated vasodilation supporting blood flow to the remodelling tissue, and inflammatory modulation helping the repair phase resolve efficiently.
- Repeat: next ESWT session at the vet-determined interval. Daily PBM between. The shockwave provides the periodic high-intensity stimulus. The light provides the daily low-intensity support. Together, the tissue receives both the trigger and the fuel.
This combination should be discussed with the vet administering the ESWT. They need to know you are adding PBM to the protocol so they can assess healing accurately and adjust the ESWT schedule based on the tissue's response to the combined approach. The vet manages the treatment plan. You manage the daily support. Both roles matter.
Side Effects and Risks: An Honest Comparison
| Risk | ESWT | PBM |
|---|---|---|
| Tissue damage | Yes — by design. Controlled microtrauma is the mechanism. Potential microfractures, cellular disruption | No. Non-thermal, non-disruptive at consumer LED power densities |
| Pain masking | Yes — significant. 72 hr rest required. Competition restriction. Risk of horse loading an injury it cannot feel | Minimal. Modest comfort support, not significant analgesia. No competition restriction |
| White hair growth | Possible at the treatment site — cosmetic but permanent | No |
| Growth plate risk (young horses) | Risk of premature closure. Not recommended for young horses with open growth plates | No structural risk |
| Overtreatment risk | Yes — excessive energy or too many sessions can cause tissue damage beyond the therapeutic level | Biphasic dose-response — excessive dose produces diminishing returns, not structural damage |
| Sedation risk | Light sedation typically required — carries standard sedation risks | No sedation needed |
| Noise / stress | ESWT machines produce loud clicking/popping sounds. Can be stressful for some horses | Silent operation. Most horses relax during sessions |
A note on young horses: ESWT should not be applied near open growth plates in young horses due to the risk of premature closure. PBM does not carry this risk. If you are considering therapy for a young horse, discuss this contraindication with your vet before any ESWT is administered.
Conclusion: The Treatment and the Practice
Shockwave and red light therapy are not two versions of the same therapy — they are different tools built on different healing philosophies. ESWT creates controlled microtrauma through acoustic mechanotransduction, deliberately disrupting tissue to trigger a repair cascade. PBM stimulates cellular repair through photochemistry, providing ATP fuel and inflammatory modulation without causing any tissue damage. One breaks to build. The other builds without breaking.
ESWT has stronger equine-specific clinical evidence for specific conditions — particularly proximal suspensory desmitis and navicular syndrome — and can reach deep structures that photons cannot. But it requires a vet, costs $200–500+ per session, masks pain for days (72-hour rest, competition restrictions), and carries real risks (microfractures, growth plate concerns, white hair). It is a treatment administered three to five times.
PBM has a broader evidence base, a more precisely characterised cellular mechanism, and an access model that allows daily owner application at no per-session cost. It carries no tissue risk, no pain masking, and no competition restriction. It is a practice maintained 300+ times per year.
Together, they cover ground that neither covers alone: ESWT provides the periodic high-intensity stimulus that restarts stalled healing in refractory conditions. PBM provides the daily cellular fuel and repair support between ESWT sessions. The vet triggers the rebuild. You maintain the environment in which the rebuild happens. The treatment and the practice — each earning its place through what the other cannot do.
Frequently Asked Questions
What is the difference between red light therapy and shockwave therapy for horses?
They work through fundamentally different healing philosophies. Shockwave (ESWT) delivers high-pressure acoustic waves that create controlled microtrauma in the tissue — deliberately disrupting cells to trigger a repair cascade through mechanotransduction. This stimulates neovascularisation, growth factor release, and tissue remodelling. Red light therapy (PBM) delivers photons at specific wavelengths that are absorbed by cytochrome c oxidase in the mitochondria, stimulating ATP production and nitric oxide release without causing any tissue disruption. ESWT breaks to build. PBM builds without breaking. They also differ in access model: ESWT requires a veterinarian, sedation, and costs $200–500+ per session. PBM is owner-applied daily with a consumer device at no per-session cost after the initial purchase.
Is shockwave or red light therapy better for horse tendon injuries?
ESWT has stronger equine-specific clinical evidence for certain tendon and ligament conditions — particularly proximal suspensory desmitis, where the AAEP position statement endorses its use. For superficial digital flexor tendon injuries, both ESWT and PBM have evidence supporting their use, though the evidence base differs in depth and study quality. PBM has the advantage of daily, owner-applied use — providing consistent cellular support throughout the weeks-long healing process — while ESWT provides periodic, vet-administered stimulus at higher intensity. They are genuinely complementary for tendon rehabilitation: ESWT administered by the vet every two to four weeks, with daily PBM between sessions supporting the cellular repair response.
Can you use red light therapy and shockwave together on a horse?
Yes — they work through different mechanisms and can be used in a complementary protocol. ESWT provides periodic high-intensity stimulus that triggers mechanotransduction-mediated repair. PBM provides daily low-intensity cellular support that fuels the repair response between shockwave sessions. Do not apply PBM within the first 24 to 48 hours after a shockwave session — the tissue needs time to respond to the mechanotransduction event. After that initial period, daily PBM resumes and supports the tissue through to the next ESWT appointment.
Does shockwave therapy mask pain in horses?
Yes — and this is a significant consideration. ESWT produces a well-documented analgesic effect that can last for several days after treatment. This is why the standard post-treatment protocol includes 72 hours of rest: the horse may not feel pain that would otherwise indicate it should not be loading the injured structure. The FEI and most competition organisations prohibit ESWT within a specified period before competition — typically five days — because a horse that cannot feel pain may perform on an injury it should be resting. Red light therapy does not produce this level of pain masking. PBM may modulate pain mediators, but it does not create the substantial numbing that ESWT does. PBM carries no competition restriction.
Why does shockwave therapy require a vet but red light therapy does not?
ESWT delivers high-energy acoustic pulses that create controlled tissue disruption — microtrauma that the body responds to with a repair cascade. This is a medical intervention with real risks: potential microfractures, white hair growth at the treatment site, premature growth plate closure in young horses, and significant pain masking that requires managed rest. The procedure requires sedation, precise anatomical targeting, and clinical judgment. PBM delivers low-energy photons that stimulate cellular activity without causing any tissue disruption. No microtrauma, no pain masking, no sedation, no structural risk at consumer LED power densities. The safety profile allows owner application without veterinary supervision for individual sessions — though the decision to use PBM for a specific condition should still be made with vet input.
